Sphingolipidoses
Also known asSphingolipidosis · Sphingolipid Storage Diseases · Sphingolipid Storage Disease · Storage Disease, Sphingolipid · Storage Diseases, Sphingolipid
Definition
A group of inherited metabolic disorders characterized by the intralysosomal accumulation of SPHINGOLIPIDS primarily in the CENTRAL NERVOUS SYSTEM and to a variable degree in the visceral organs. They are classified by the enzyme defect in the degradation pathway and the substrate accumulation (or storage). Clinical features vary in subtypes but neurodegeneration is a common sign.
MeSH classification
- C10.228.140.163.100.435.825
- C16.320.565.189.435.825
- C16.320.565.398.641.803
- C16.320.565.595.554.825
- C18.452.132.100.435.825
- C18.452.584.563.641.803
- C18.452.648.189.435.825
- C18.452.648.398.641.803
- C18.452.648.595.554.825
Need clinical context, treatments, or patient-language explanation?
Ask GoDavaii AI about SphingolipidosesCommon questions about Sphingolipidoses
What does Sphingolipidoses mean in medicine?
Is Sphingolipidoses known by any other names?
Where does Sphingolipidoses sit in the medical classification?
Where can I get a plain-language explanation of Sphingolipidoses?
Source: NIH MeSH 2026 (D013106) — National Library of Medicine, public domain. View official MeSH record ↗